Julien Edeline

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 47

Top Topics

Epidermal Growth Factor Receptor

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Targeted oncology

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Antoine Lebeaud, Leony Antoun, Jane-Rose Paccard, Julien Edeline, Héloïse Bourien, Nadim Fares, Christophe Tournigand, Thierry Lecomte, David Tougeron, Vincent Hautefeuille, Angélique Viénot, Julie Henriques, Nicolas Williet, Jean-Baptiste Bachet, Cristina Smolenschi, Antoine Hollebecque, Teresa Macarulla, Florian Castet, David Malka, Cindy Neuzillet, Dewi Vernerey, Alice Boilève, Anthony Turpin
Management of biliary tract cancers in early-onset patients: A nested multicenter retrospective study of the ACABI GERCOR PRONOBIL cohort. Liver international : official journal of the International Association for the Study of the Liver 44 (8) (2024)
Antoine Lebeaud, Leony Antoun, Jane-Rose Paccard, Julien Edeline, Héloïse Bourien, Nadim Fares, Christophe Tournigand, Thierry Lecomte, David Tougeron, Vincent Hautefeuille, Angélique Viénot, Julie Henriques, Nicolas Williet, Jean-Baptiste Bachet, Cristina Smolenschi, Antoine Hollebecque, Teresa Macarulla, Florian Castet, David Malka, Cindy Neuzillet, Dewi Vernerey, Alice Boilève, Anthony Turpin
Management of biliary tract cancers in early-onset patients: A nested multicenter retrospective study of the ACABI GERCOR PRONOBIL cohort. Liver international : official journal of the International Association for the Study of the Liver (2024)
Etienne Garin, Xavier Palard, Yan Rolland, Samuel Le Sourd, Nicolas Lepareur, Valérie Ardisson, Christelle Bouvry, Sophie Laffont, Boris Campillo-Gimenez, Eric Bellissant, Julien Edeline
188 Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study). Cancers 15 (8) (2023)
Giuseppe Cabibbo, Julien Edeline
The prognostic role of tumour progression and liver function at progression under immunotherapy for hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Cindy Neuzillet, Pascal Artru, Eric Assenat, Julien Edeline, Xavier Adhoute, Jean-Christophe Sabourin, Anthony Turpin, Romain Coriat, David Malka
Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective. Targeted oncology 18 (1) (2023)
Cindy Neuzillet, Pascal Artru, Eric Assenat, Julien Edeline, Xavier Adhoute, Jean-Christophe Sabourin, Anthony Turpin, Romain Coriat, David Malka
Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective. Targeted oncology 18 (1) (2023)
Victoria Foy, Mairéad Geraldine McNamara, Juan W Valle, Angela Lamarca, Julien Edeline, Richard A Hubner
Current Evidence for Immune Checkpoint Inhibition in Advanced Hepatocellular Carcinoma. Current oncology (Toronto, Ont.) 30 (9) (2023)
Constance d'Abrigeon, Mairéad Geraldine McNamara, Samuel Le Sourd, Angela Lamarca, Astrid Lièvre, Héloïse Bourien, Alexandre Peinoit, Thomas Uguen, Richard A Hubner, Juan W Valle, Julien Edeline
Influence of cirrhosis on outcomes of patients with advanced intrahepatic cholangiocarcinoma receiving chemotherapy. British journal of cancer (2023)
Angela Lamarca, Julien Edeline
Adjuvant treatment for biliary tract tumors: lost in a maze? Hepatology (Baltimore, Md.) (2023)
Julien Edeline, Jean-Frédéric Blanc
Difficulties for providing evidence in hepatocellular carcinoma with Child-Pugh B liver function. Liver international : official journal of the International Association for the Study of the Liver 43 (2) (2023)
Simon Gray, Octave Letissier, Constance d'Abrigeon, Dinakshi Shah, Stephen Wardell, Olusola Faluyi, Angela Lamarca, Richard A Hubner, Julien Edeline, Juan W Valle, Mairéad Geraldine McNamara
Third-Line Palliative Systemic Therapy for Advanced Biliary Tract Cancer: Multicentre Review of Patterns of Care and Outcomes. Cancers 15 (11) (2023)
Cindy Neuzillet, Pascal Artru, Eric Assenat, Julien Edeline, Xavier Adhoute, Jean-Christophe Sabourin, Anthony Turpin, Romain Coriat, David Malka
Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective. Targeted oncology 18 (1) (2023)
Cindy Neuzillet, Pascal Artru, Eric Assenat, Julien Edeline, Xavier Adhoute, Jean-Christophe Sabourin, Anthony Turpin, Romain Coriat, David Malka
Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective. Targeted oncology 18 (1) (2023)
Cindy Neuzillet, Pascal Artru, Eric Assenat, Julien Edeline, Xavier Adhoute, Jean-Christophe Sabourin, Anthony Turpin, Romain Coriat, David Malka
Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective. Targeted oncology (2023)
Etienne Garin, Xavier Palard, Yan Rolland, Samuel Le Sourd, Nicolas Lepareur, Valérie Ardisson, Christelle Bouvry, Sophie Laffont, Boris Campillo-Gimenez, Eric Bellissant, Julien Edeline
188 Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study). Cancers 15 (8) (2023)
Giuseppe Cabibbo, Julien Edeline
The prognostic role of tumour progression and liver function at progression under immunotherapy for hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Héloïse Bourien, Chiara Carlotta Pircher, Boris Guiu, Angela Lamarca, Juan W Valle, Monica Niger, Julien Edeline
Locoregional Treatment in Intrahepatic Cholangiocarcinoma: Which Treatment for Which Patient? Cancers 15 (17) (2023)
Cindy Neuzillet, Pascal Artru, Eric Assenat, Julien Edeline, Xavier Adhoute, Jean-Christophe Sabourin, Anthony Turpin, Romain Coriat, David Malka
Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective. Targeted oncology 18 (1) (2023)
Julien Edeline, Tim Meyer, Jean-Frédéric Blanc, Jean-Luc Raoul
New Challenges Facing Systemic Therapies of Advanced HCC in the Era of Different First-Line Immunotherapy-Based Combinations. Cancers 14 (23) (2022)
Emeric Boisteau, Céline Posseme, Federico Di Modugno, Julien Edeline, Cédric Coulouarn, Roman Hrstka, Andrea Martisova, Frédéric Delom, Xavier Treton, Leif A Eriksson, Éric Chevet, Astrid Lièvre, Eric Ogier-Denis
Anterior gradient proteins in gastrointestinal cancers: from cell biology to pathophysiology. Oncogene 41 (42) (2022)
Simon Gray, Angela Lamarca, Julien Edeline, Heinz-Josef Klümpen, Richard A Hubner, Mairéad Geraldine McNamara, Juan W Valle
Targeted Therapies for Perihilar Cholangiocarcinoma. Cancers 14 (7) (2022)
Julien Edeline, Tim Meyer, Jean-Frédéric Blanc, Jean-Luc Raoul
New Challenges Facing Systemic Therapies of Advanced HCC in the Era of Different First-Line Immunotherapy-Based Combinations. Cancers 14 (23) (2022)
Sonia Zaibet, Vincent Hautefeuille, Edouard Auclin, Astrid Lièvre, David Tougeron, Mathieu Sarabi, Marine Gilabert, Julie Wasselin, Julien Edeline, Pascal Artru, Dominique Bechade, Clémence Morin, Agnes Ducoulombier, Gilles Manceau, Simon Pernot
Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study. British journal of cancer 126 (10) (2022)
Julien Edeline, David Malka
Capecitabine: Still a Standard Option in the Adjuvant Setting of Biliary Tract Cancer? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (31) (2022)
Julien Edeline, Yan Rolland, Boris Campillo-Gimenez, Héloïse Bourien, Marion Trochet, Etienne Garin, Karim Boudjema
Selective Internal Radiation Therapy (Yttrium-90 Glass Microspheres) Combined with Capecitabine in the Neoadjuvant Setting of Operable Intrahepatic CHOlangiocarcinoma: The SIROCHO Trial Design. Annals of surgical oncology (2022)
Gontran Verset, Ivan Borbath, Mark Karwal, Chris Verslype, Hans Van Vlierberghe, Adel Kardosh, Vittorina Zagonel, Per Stål, Debashis Sarker, Daniel H Palmer, Arndt Vogel, Julien Edeline, Stephane Cattan, Masatoshi Kudo, Ann-Lii Cheng, Sadahisa Ogasawara, Bruno Daniele, Stephen L Chan, Jennifer J Knox, Shukui Qin, Abby B Siegel, Michael Chisamore, Ken Hatogai, Anran Wang, Richard S Finn, Andrew X Zhu
Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (12) (2022)
Julien Edeline, Tim Meyer, Jean-Frédéric Blanc, Jean-Luc Raoul
New Challenges Facing Systemic Therapies of Advanced HCC in the Era of Different First-Line Immunotherapy-Based Combinations. Cancers 14 (23) (2022)
Julien Edeline, Tim Meyer, Jean-Frédéric Blanc, Jean-Luc Raoul
New Challenges Facing Systemic Therapies of Advanced HCC in the Era of Different First-Line Immunotherapy-Based Combinations. Cancers 14 (23) (2022)
Jean-Luc Raoul, Julien Edeline, Victor Simmet, Camille Moreau-Bachelard, Marine Gilabert, Jean-Sébastien Frenel
Long-Term Use of Proton Pump Inhibitors in Cancer Patients: An Opinion Paper. Cancers 14 (5) (2022)
Corentin Louis, Julien Edeline, Cédric Coulouarn
Targeting the tumor microenvironment in cholangiocarcinoma: implications for therapy. Expert opinion on therapeutic targets 25 (2) (2021)
Antonin Vary, Loïc Lebellec, Frédéric Di Fiore, Nicolas Penel, Claire Cheymol, Emilia Rad, Farid El Hajbi, Astrid Lièvre, Julien Edeline, André Michel Bimbai, Marie-Cécile Le Deley, Anthony Turpin
FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma. Therapeutic advances in medical oncology 13 (2021)
Héloïse Bourien, Angela Lamarca, Mairéad G McNamara, Richard A Hubner, Juan W Valle, Julien Edeline
Druggable molecular alterations in bile duct cancer: potential and current therapeutic applications in clinical trials. Expert opinion on investigational drugs 30 (9) (2021)
Richard A Hubner, Helen L Reeves, Julien Edeline
Combined hepatocellular-cholangiocarcinoma - More questions than answers. Liver international : official journal of the International Association for the Study of the Liver 41 (6) (2021)
Samuel Roger, Julien Edeline, Boris Campillo-Gimenez, Elodie Ventroux, Marie-Eve Rougé Bugat, Anthony Chapron
Adverse events of targeted therapies reported by patients with cancer treated in primary care. The European journal of general practice 26 (1) (2021)
Céline Lescure, Florian Estrade, Maud Pedrono, Boris Campillo-Gimenez, Samuel Le Sourd, Marc Pracht, Xavier Palard, Héloïse Bourien, Léa Muzellec, Thomas Uguen, Yan Rolland, Etienne Garin, Julien Edeline
ALBI Score Is a Strong Predictor of Toxicity Following SIRT for Hepatocellular Carcinoma. Cancers 13 (15) (2021)
Jean-Frédéric Blanc, Faiza Khemissa, Jean-Pierre Bronowicki, Carole Monterymard, Jean-Marc Perarnau, Vincent Bourgeois, Stéphane Obled, Meher Ben Abdelghani, Isabelle Mabile-Archambeaud, Roger Faroux, Jean-François Seitz, Christophe Locher, Hélène Senellart, Anne-Laure Villing, Franck Audemar, Charlotte Costentin, Gaël Deplanque, Sylvain Manfredi, Julien Edeline, null null
Phase 2 trial comparing sorafenib, pravastatin, their combination or supportive care in HCC with Child-Pugh B cirrhosis. Hepatology international 15 (1) (2021)
Camille Goislard de Monsabert, Yann Touchefeu, Boris Guiu, Boris Campillo-Gimenez, Olivier Farges, David Tougeron, Isabelle Baumgaertner, Ahmet Ayav, Luc Beuzit, Marc Pracht, Astrid Lièvre, Samuel Le Sourd, Karim Boudjema, Yan Rolland, Etienne Garin, Eveline Boucher, Julien Edeline
Selective Internal Radiation Combined with Chemotherapy Maintains the Quality of Life in Intrahepatic Cholangiocarcinomas. Current oncology (Toronto, Ont.) 28 (6) (2021)
Léa Muzellec, Héloïse Bourien, Julien Edeline
Patients' Experience of Systemic Treatment of Hepatocellular Carcinoma: A Review of the Impact on Quality of Life. Cancers 14 (1) (2021)
Jean Marc Phelip, Jérôme Desrame, Julien Edeline, Emilie Barbier, Eric Terrebonne, Pierre Michel, Hervé Perrier, Laetitia Dahan, Vincent Bourgeois, Faiza Khemissa Akouz, Emilie Soularue, Valérie Lebrun Ly, Yann Molin, Thierry Lecomte, François Ghiringhelli, Romain Coriat, Samy Louafi, Cindy Neuzillet, Sylvain Manfredi, David Malka, null null
Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Jorge Adeva, Bruno Sangro, Maximiliano Salati, Julien Edeline, Adelaida La Casta, Alessandro Bittoni, Rosanna Berardi, Jordi Bruix, Juan W Valle
Medical treatment for cholangiocarcinoma. Liver international : official journal of the International Association for the Study of the Liver (2020)
Julien Edeline, Yan Rolland, Etienne Garin
Abscopal Effect After SIRT: It Exists, but How Could We Use It? Cardiovascular and interventional radiology 43 (11) (2020)
Tim A Labeur, Sarah Berhane, Julien Edeline, Jean-Frederic Blanc, Dominic Bettinger, Tim Meyer, Jeroen L A Van Vugt, David W G Ten Cate, Robert A De Man, Ferry A L M Eskens, Alessandro Cucchetti, Laura Jayne Bonnett, Otto M van Delden, Heinz-Josef Klümpen, R Bart Takkenberg, Philip J Johnson
Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib. Liver international : official journal of the International Association for the Study of the Liver 40 (1) (2019)
Héloïse Bourien, Xavier Palard, Yan Rolland, Fanny Le Du, Luc Beuzit, Thomas Uguen, Samuel Le Sourd, Marc Pracht, Vincent Manceau, Astrid Lièvre, Karim Boudjema, Etienne Garin, Julien Edeline
Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experience. European journal of nuclear medicine and molecular imaging 46 (3) (2018)
Nikhil Chauhan, Janet Bukovcan, Eveline Boucher, David Cosgrove, Julien Edeline, Bonnie Hamilton, Laura Kulik, Fayaz Master, Riad Salem
Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial. JMIR research protocols 7 (8) (2018)
Julien Edeline, Jean-Frédéric Blanc, Philip Johnson, Boris Campillo-Gimenez, Paul Ross, Yuk Ting Ma, Judy King, Richard A Hubner, Kate Sumpter, Suzanne Darby, Jeff Evans, Chinenye Iwuji, Daniel Swinson, Peter Collins, Kinnari Patel, Iqtedar Muazzam, Daniel H Palmer, Tim Meyer
A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma. Liver international : official journal of the International Association for the Study of the Liver 36 (12) (2016)
Etienne Garin, Yan Rolland, Marc Pracht, Samuel Le Sourd, Sophie Laffont, Habiba Mesbah, Laure-Anne Haumont, Laurence Lenoir, Tanguy Rohou, Vanessa Brun, Julien Edeline
High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with 90 Y-loaded glass microsphere radioembolization. Liver international : official journal of the International Association for the Study of the Liver 37 (1) (2016)
Julien Edeline, Laurence Crouzet, Boris Campillo-Gimenez, Yan Rolland, Marc Pracht, Anne Guillygomarc'h, Karim Boudjema, Laurence Lenoir, Xavier Adhoute, Tanguy Rohou, Eveline Boucher, Bruno Clément, Jean-Frédéric Blanc, Etienne Garin
Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis. European journal of nuclear medicine and molecular imaging 43 (4) (2015)